Invention Grant
- Patent Title: Functionalized 1,3-benzene diols and their method of use for the treatment of hepatic encephalopathy
-
Application No.: US14781081Application Date: 2015-01-09
-
Publication No.: US09611213B2Publication Date: 2017-04-04
- Inventor: Douglas E Brenneman , William Alvin Kinney , Mark McDonnell , Dean Petkanas
- Applicant: Kannalife, Inc.
- Applicant Address: US NY Huntington
- Assignee: KANNALIFE SCIENCES, INC.
- Current Assignee: KANNALIFE SCIENCES, INC.
- Current Assignee Address: US NY Huntington
- Agency: Caesar Rivise, PC
- International Application: PCT/US2015/010827 WO 20150109
- International Announcement: WO2015/106108 WO 20150716
- Main IPC: C07D205/04
- IPC: C07D205/04 ; C07B59/00 ; C07D249/04 ; C07D205/06
Abstract:
Pharmaceutical compositions of the invention include novel functionalized 1,3-benzenediols having a disease-modifying action in the treatment of hepatic encephalopathy and related conditions. Pharmaceutical compositions of the invention further include novel neuroprotective agents.
Public/Granted literature
Information query
